Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-013702

Chief Financial Officer sold 398 shares at $10.71 ($4,263)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Trigilio Jeffrey Chief Financial Officer 2023-04-18 Sale −398 $10.71 $4,263 87,287 D
Open-market sales · 398 sh · avg $10.71 · $4,263
Loading xslF345X04/ownership.xml…